Carbapenem-Resistant Acinetobacter spp Infection in Critically Ill Patients With Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic

BACKGROUND: Carbapenem-resistant Acinetobacter baumannii infections are difficult to treat and are a significant public health threat due to intrinsic/acquired resistance and limited treatment options. METHODS: A retrospective, observational cohort study in patients receiving cefiderocol via Shionog...

Descripción completa

Detalles Bibliográficos
Autores principales: Giannella, Maddalena, Verardi, Stefano, Karas, Andreas, Abdel Hadi, Hasania, Dupont, Hervé, Soriano, Alex, Santerre Henriksen, Anne, Cooper, Andrew, Falcone, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368198/
https://www.ncbi.nlm.nih.gov/pubmed/37496600
http://dx.doi.org/10.1093/ofid/ofad329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368198/
https://www.ncbi.nlm.nih.gov/pubmed/37496600
http://dx.doi.org/10.1093/ofid/ofad329

Ejemplares similares